{"organizations": [], "uuid": "452b7cfe307de310ff7247761d4708b0bc0d5fb5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180419.html", "section_title": "Archive News &amp; Video for Thursday, 19 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-quantum-genomics-presents-its-3-ye/brief-quantum-genomics-presents-its-3-year-strategic-plan-idUSFWN1RW0TX", "country": "US", "domain_rank": 408, "title": "BRIEF-Quantum Genomics Presents Its 3-Year Strategic Plan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-04-20T00:27:00.000+03:00", "replies_count": 0, "uuid": "452b7cfe307de310ff7247761d4708b0bc0d5fb5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-quantum-genomics-presents-its-3-ye/brief-quantum-genomics-presents-its-3-year-strategic-plan-idUSFWN1RW0TX", "ord_in_thread": 0, "title": "BRIEF-Quantum Genomics Presents Its 3-Year Strategic Plan", "locations": [], "entities": {"persons": [{"name": "jean-philippe milon", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19 (Reuters) - QUANTUM GENOMICS SA:\n* PRESENTS ITS 3-YEAR STRATEGIC PLAN.\n* ARTERIAL HYPERTENSION: COMPLETION OF NEW-HOPE STUDY BROUGHT FORWARD TO DECEMBER 2018\n* HEART FAILURE: EARLY LAUNCH OF A PHASE IIB STUDY IN 4(TH) QUARTER 2018, ON BASIS OF GOOD PRODUCT SAFETY IN HEART FAILURE PATIENTS\n* TO SIGN A STRATEGIC PARTNERSHIP OR LICENSE AGREEMENT WITH A PHARMACEUTICAL GROUP WITHIN 24 MONTHS\n* JEAN-PHILIPPE MILON NOW ASSUMES POSITION OF CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-20T00:27:00.000+03:00", "crawled": "2018-04-20T11:26:07.009+03:00", "highlightTitle": ""}